[1]范帅 常保东* 王雷阳 张力 葛永超 冯金顺 张明伟 任行飞 费兴业 周诣桐.低功率60 W(1.5 J×40 Hz)钬激光剜除术治疗良性前列腺增生的临床疗效[J].中国微创外科杂志,2022,01(4):318-322.
　Fan Shuai,Chang Baodong,Wang Leiyang,et al.Clinical Efficacy of 60 W (1.5 J×40 Hz) Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia[J].Chinese Journal of Minimally Invasive Surgery,2022,01(4):318-322.
点击复制

低功率60 W(1.5 J×40 Hz)钬激光剜除术治疗良性前列腺增生的临床疗效()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2022年4期
页码:
318-322
栏目:
临床研究
出版日期:
2022-07-20

文章信息/Info

Title:
Clinical Efficacy of 60 W (1.5 J×40 Hz) Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia
作者:
范帅 常保东* 王雷阳 张力 葛永超 冯金顺 张明伟 任行飞 费兴业 周诣桐
(郑州市第三人民医院泌尿外科，郑州450000)
Author(s):
Fan Shuai;  Chang Baodong;  Wang Leiyang;  et al.
Department of Urology, Zhengzhou Third People’s Hospital, Zhengzhou 450000, China
关键词:
低功率; 高功率; 前列腺钬激光剜除术; 良性前列腺增生
Keywords:
Low power; High power; Holmium laser enucleation of the prostate; Benign prostatic hyperplasia
文献标志码:
A
摘要:
目的探讨低功率60 W(1.5 J×40 Hz)经尿道前列腺钬激光剜除术(holmium laser enucleation of the prostate，HoLEP)治疗良性前列腺增生(benign prostatic hyperplasia，BPH)的临床疗效及安全性。方法回顾分析我院2018年6月~2020年6月120例需要手术治疗的BPH患者的临床资料，依据钬激光参数不同分为2组：60 W组(1.5 J×40 Hz低功率HoLEP)和100 W组(2.5 J×40 Hz高功率HoLEP)，各60例，比较2组手术时间、术后并发症、膀胱冲洗时间、留置导尿管时间及住院时间等，手术前后国际前列腺症状评分(International Prostate Symptom Score，IPSS)、生活质量(quality of life，QOL)评分、最大尿流率(Qmax)、残余尿量（residual urine,RU）改善情况。结果60 W组与100 W组手术时间［(56.6±7.3)min vs.(55.1±6.3)min,t=1.207,P=0.230］，术后并发症发生率［3.3%(2/60) vs. 8.3%(5/60)， χ２=0.607,P=0.436］、膀胱冲洗时间［(1.6±0.3)d vs.(1.7±0.2)d,t=-0.571,P=0.569］、留置导尿管时间［(1.9±0.4)d vs.(2.0±0.5)d,t=-1.379,P=0.170］ 和术后住院时间［(3.6±0.6)d vs.(3.7±0.5)d,t=-0.866,P=0.388］差异无显著性。术后2个月随访，2组术后IPSS、QOL、Qmax、RU与术前比较均有明显改善(P＜0.05)。暂时性尿失禁60 W组1例，100 W组3例，2组比较差异无显著性(P=0.611)。结论低功率60 W(1.5 J×40 Hz)HoLEP治疗BPH安全可靠，与高功率的疗效相当。
Abstract:
ObjectiveTo evaluate the safety and efficacy of holmium laser enucleation of the prostate (HoLEP) with low power 60 W (1.5 J×40 Hz) laser device.MethodsFrom June 2018 to June 2020, 120 patients with benign prostatic hyperplasia (BPH) underwent HoLEP in our hospital. The patients were divided into two groups. In the lowpower group (60 patients), the HoLEP were performed with 60 W setting (1.5 J×40 Hz); while in the highpower group (60 patients), the HoLEP were performed with 100 W setting (2.5 J×40 Hz). The operative time, postoperative complications, bladder flushing time, catheter retention time and hospitalization time were compared between the two groups. The preoperative and postoperative international prostate symptom score (IPSS), quality of life (QOL）, Qmax and residual urine (RU) were compared between the two groups.ResultsThere were no significant differences between the two groups regarding operative time ［(56.6±7.3) min vs. (55.1±6.3) min, t=1.207, P=0230］, postoperative complications ［3.3% (2/60) vs. 8.3% (5/60), χ2=0.607, P=0.436］, bladder flushing time ［(1.6±03) d vs. (1.7±0.2) d, t=-0.571, P=0.569］, catheter retention time ［(1.9±0.4) d vs. (2.0±0.5) d, t=-1.379, P=0.170］ and hospitalization time ［(3.6±0.6) d vs. (3.7±0.5) d, t=-0.866, P=0388］. Postoperative followups for 2 months showed significant improvement in IPSS, QOL, Qmax, and RU (P<0.05) in both groups as compared with the baseline data. Temporary urinary incontinence was found in 1 case in the lowpower group and 3 cases in the highpower group, without significant difference between the two groups (P=0.611).ConclusionHoLEP at 60 W (1.5 J×40 Hz) is safe and reliable for BPH, being as efficient as the highpower enucleation.

参考文献/References:

[1]罗建庭.经尿道钬激光前列腺剜除术和经尿道前列腺电切术后疗效对比的Meta分析.中国药物与临床,2019,19(7):1176-1177.
[2]Zhang Z, Luo F, Su Y, et al. Management of green light laser plus transurethral resection of prostate for elderly men. Medicine(Baltimore),2018,97(33):e11862.
[3]Kathryn BE. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms prevalence and incident rates. Urol Clin N Am,2016,43(3):289-297.
[4]Glybochko PV, Rapoport LM, Enikeev ME, et al. Holmium laser enucleation of the prostate(HoLEP) for small, large and giant prostatic hyperplasia: tips and tricks. Urologia,2017,84(3):169-173.
[5]刘可,肖春雷,马潞林.钬激光前列腺剜除术治疗良性前列腺增生的自学学习曲线.中国微创外科杂志,2016,16(1):31-34.
[6]吕远,许长宝,万优,等.摩西技术120 W钬激光“三线一面”法在高风险良性前列腺增生合并膀胱结石治疗中的体会.临床外科杂志,2021,29(2):117-119.
[7]黄健，主编.中国泌尿外科和男科疾病诊断治疗指南.北京：科学出版社，2020.225.
[8]刘可,张帆,肖春雷,等.低功率钬激光“七步两叶法”前列腺剜除术治疗良性前列腺增生.北京大学学报(医学版),2019,51(6):1159-1164.
[9]Montorsi F, Wilson TG, Rosen RC, et al. Best practices in robotassisted radical prostatectomy: Recommendations of the pasadena consensus panel. Eur Urol,2012,62(3):368-381.
[10]彭磊,李金泽,游成宇,等.经尿道钬激光前列腺剜除术和经尿道等离子前列腺剜除术治疗良性前列腺增生的安全性和有效性的系统评价.华西医学,2021,36(7):919-929.
[11]郭强,肖毅,李建文,等. HoLEP与TUPKP治疗BPH的安全性和疗效的meta分析.中华男科学杂志,2016,22(10):914-922.
[12]Oh SJ. Current surgical techniques of enucleation in holmium laser enucleation of the prostate. Investig Clin Urol,2019,60(5):333-342.
[13]蒋双键,莫承强,桂程鹏,等.钬激光在泌尿系腔道模型中热效应的实验研究.中华泌尿外科杂志,2021,42(3):220-225.
[14]Becker B，Gmss AJ，Netsch C． Safety and efficacy using a lowpowered holmium laser for enucleation of the prostate (HoLEP): 12month results from a prospective lowpower HoLEP series．World J Urol,2018,36(3):441-447.
[15]郑宇飞,冯超,张保朝,等.小功率钬激光前列腺剜除术的安全性及疗效分析.国际泌尿系统杂志,2019,39(5):826-829.
[16]尤平洪,朱延杰,赵文武,等.小功率钬激光前列腺剜除术在良性前列腺增生治疗中的临床价值.微创泌尿外科杂志,2017,6(5):309-311.
[17]Kallidonis P, Amanatides L, Panagopoulos V, et al. Does the heat generation by the thulium: Yttrium aluminum garnet laser in the irrigation fluid allow its use on the upper urinary tract? An experimental study. J Endourol,2016,30(4):422-427.
[18]Wollin DA, Carlos EC, Tom WR, et al. Effect of laser settings and irrigation rates on ureteral temperature during holmium laser lithotripsy, an in vitro model. J Endourol,2018,32(1):59-63.
[19]刘凡,原小斌,张敏,等.泌尿系结石钬激光碎石热效应研究进展.国际泌尿系统杂志,2019,39(2):351-353.
[20]魏巍,张刚,夏玉军.基于前列腺解剖的比较治疗良性前列腺增生不同微创术式的临床研究.泌尿外科杂志(电子版),2020,12(3):36-41.
[21]胡建明,蒯留牛,戴弋,等.低功率HoLEP与TURP对BPH患者疗效的影响及术后应激性尿失禁的危险因素分析.国际泌尿系统杂志,2021,41(4):588-592.

备注/Memo

备注/Memo:
*通讯作者，Email：changbaodong@126.com
更新日期/Last Update: 2022-07-21